News

Injectafer (US brand name of Ferinject) is a non-dextran intravenous iron replacement therapy comprising Ferric carboxymaltose as the active pharmaceutical ingredient. The first trial compared Injectafer to either

The placebo-controlled, randomized study was designed to assess drug’s safety, tolerability along with pharmacokinetic parameters. In the Phase 1 SAD study, the maximum tolerated single dose was defined

The acquisition allow the company to commercialize all Shalaks’ products under the Invida brand. Invida will market Shalaks’ dermatology brands, including topical anti-acne, anti-fungal, anti-scar, anti-pigmentation, sun screens

Valsartan is a generic version of Diovan (Valsartan) and Valsartan HCTZ is the generic version Co-Diovan (Valsartan HCTZ), both of which are from Novartis and are used to

PMBL are used to prevent acute, sub-acute, recurrent or chronic infections of the upper and lower airways and the bronchopulmonary tree, in addition to acute exacerbations in chronic

Palifosfamide, a DNA cross-linker in class with bendamustine, ifosfamide and cyclophosphamide, is undergoing a randomised double-blinded placebo-controlled Phase 3 trial for the treatment of metastatic soft tissue sarcoma.

Pradaxa, an oral anticoagulant, has been approved for the prevention of stroke in AF in more than 50 countries across the globe. RE-LY was a global, Phase III,

Qutenza (capsaicin) 8% patch is a localised dermal delivery system comprising prescription strength capsaicin. Qutenza is currently FDA approved as a 60-minute application for the management of neuropathic

Acetaminophen and Codeine Phosphate Oral Solution is available in a dose strength of 120mg/12mg per 5mL. Qualitest provides generic pharmaceuticals and supplies them based on total prescriptions filled.